Table 1.

Characteristics at study entry of 40 patients with clinically active JIA. Except where otherwise indicated, values are median (interquartile range).

All Patients, n = 40
Clinical characteristics
  No. (%) female25 (62.5)
  Age at study visit, yrs, mean (SD)12.2 (2.8)
  Disease duration at study visit, yrs2.3 (0.7–5.0)
  PGA of overall disease activitya31 (20–48)
  Patient’s global assessment of overall well beinga17 (1–48)
  Patient’s pain assessmenta26 (3–67)
  CHAQ scoreb0.625 (0.125–1.124)
  No. active joints2 (1–3)
  No. joints with limited range of motion1 (0–2)
  ESR, mm/hc5 (2–8)
  CRP, mg/dld1 (1–1)
JAMRIS scores, mean (min–max)
  Synovial hypertrophy, 0–122.03 (0–12)
  Bone marrow changes, 0–240.85 (0–7)
  Cartilage lesions, 0–240.08 (0–2)
  Bone erosions, 0–240.05 (0–1)
  • a Measured on a 0–100 mm visual analog scale (0 = best, 100 = worst).

  • b Units; 0 = best, 3 = worst.

  • c Normal < 15 mm/h.

  • d Normal < 0.6 mg/dl.

  • PGA: physician’s global assessment; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; JIA: juvenile idiopathic arthritis; CHAQ: Childhood Health Assessment Questionnaire; JAMRIS: Juvenile Arthritis Magnetic Resonance Imaging Scoring system.